SINGAPORE: People living with asthma are most vulnerable when taking a breath of air, yet their use of widely prescribed ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
Aptar Digital Health's HeroTracker® Sense has been granted by the U.S Food and Drug Administration 510(k) clearance as a ...
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...
Prescribing inhalers offers physicians a chance to impact climate change — but switching to greener options comes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results